One company, Zogenix in San Diego, plans to apply early next year to begin marketing its drug, Zohydro, a timed-release drug meant for managing moderate to severe pain. Experts are particularly worried about the potential for abuse because users can crush the drug for faster relief.
April Rovero, president of the National Coalition Against Prescription Drug Abuse, thinks it could be the next OxyContin. As feared with Zohydro, users crushed OxyContin to bypass the timed-release formula. Oxycodone, the main pain-relieving agent in OxyContin, is now the most abused medication in the U.S.
Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!
Related Articles on Pain Management:
How Does Pain Management Physicians’ Compensation Stack Up: A Comparison to Physicians in Other Top ASC Specialties
Study: Listening to Music Effective for Pain Relief
Drs. Gary Franklin and Jeff Thompson: Washington State is Combating Opioid Abuse
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
